Previous close | 9,877.51 |
Open | 0.00 |
Bid | 0.00 x N/A |
Ask | 0.00 x N/A |
Day's range | 9,175.72 - 9,175.72 |
52-week range | 6,443.40 - 9,991.55 |
Volume | |
Avg. volume | 2,432 |
Market cap | N/A |
Beta (5Y monthly) | 0.63 |
PE ratio (TTM) | 12.03 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing novel treatments for severe neurodegenerative diseases, today provides a business update.